RBM3 and prostate cancer: In prostate cancer PC3 cells, overexpression of RBM3 protein resulted in decreased expression of CD44 isoform 3 (CD44v8-v10) and an increased expression of CD44 isoform 4 (CD44s) (Zeng et al., 2013).